Abstract:Diabetic neuropathy is one of the prevalent and debilitating microvascular complications of diabetes mellitus, affecting a significant portion of the global population. Relational preclinical animal models are essential to understand its pathophysiology and develop effective treatments. This abstract provides an overview of current knowledge and advancements in such models. Various animal models have been developed to mimic the multifaceted aspects of human diabetic neuropathy, including both type 1 and type 2 diabetes. These models involve rodents (rats and mice) and larger animals like rabbits and dogs. Induction of diabetic neuropathy in these models is achieved through chemical, genetic, or dietary interventions, such as diabetogenic agents, genetic modifications, or high-fat diets. Preclinical animal models have greatly contributed to studying the intricate molecular and cellular mechanisms underlying diabetic neuropathy. They have shed light on hyperglycemia-induced oxidative stress, neuroinflammation, mitochondrial dysfunction, and altered neurotrophic factor signaling. Additionally, these models have allowed for the investigation of morphological changes, functional alterations, and behavioral manifestations associated with diabetic neuropathy. These models have also been crucial for evaluating the efficacy and safety of potential therapeutic interventions. Novel pharmacological agents, gene therapies, stem cell-based approaches, exercise, dietary modifications, and neurostimulation techniques have been tested using these models. However, limitations and challenges remain, including physiological differences between humans and animals, complex neuropathy phenotypes, and the need for translational validation. In conclusion, preclinical animal models have played a vital role in advancing our understanding and management of diabetic neuropathy. They have enhanced our knowledge of disease mechanisms, facilitated the development of novel treatments, and provided a platform for translational research. Ongoing efforts to refine and validate these models are crucial for future treatment developments for this debilitating condition.

An Overview Of Valuable Scientific Models For Diabetes Mellitus

Review on In-vitro Techniques and In-vivo Animals Models for Screening Diabetes and Diabetic Complications

Progress in experimental models to investigate the in vivo and in vitro antidiabetic activity of drugs

Future Perspective of Diabetic Animal Models

Experimental animal models for diabetes and its related complications—a review

Research('s) Sweet Hearts: Experimental Biomedical Models of Diabetic Cardiomyopathy

[Advances in in vitro assessment models and screening methods for blood glucose-lowering medications]

Goto-Kakizaki Rats: Its Suitability As Non-Obese Diabetic Animal Model For Spontaneous Type 2 Diabetes Mellitus

Current status and patent prospective of animal models in diabetic research

Study of the pathogenesis and treatment of diabetes mellitus through animal models

Application of Animal Models in Diabetic Cardiomyopathy

Preclinical Models for Type 1 Diabetes Mellitus - A Practical Approach for Research

Current advancement in the preclinical models used for the assessment of diabetic neuropathy

Animal Research for Type 2 Diabetes Mellitus, Its Limited Translation for Clinical Benefit, and the Way Forward

Experimental approaches for induction of diabetes mellitus and assessment of antidiabetic activity: An in vitro and in vivo methodological review

Animal models for type 1 and type 2 diabetes: advantages and limitations

Recent progress in artificial intelligence and machine learning for novel diabetes mellitus medications development

Developing the UVA/Padova Type 1 Diabetes Simulator: Modeling, Validation, Refinements, and Utility

Exploring cutting-edge approaches in diabetes care: from nanotechnology to personalized therapeutics

Spontaneous Type 2 Diabetic Rodent Models

Diabetes: a review of its pathophysiology, and advanced methods of mitigation